LianBio Sponsored ADR (LIANY) vs Veru Inc. (VERU)

LianBio Sponsored ADR and Veru Inc. are both Biotechnology companies. LianBio Sponsored ADR and Veru Inc. are of similar size ($35.1M and $34.2M). Veru Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. Across the 10 metrics below, LianBio Sponsored ADR leads on 8 and Veru Inc. on 2.

Valuation

Metric LIANY VERU Biotechnology median
P/E 0.01 n/m 10.60
P/S n/m 2.65 9.40
P/B 0.01 1.74 2.13
Price to free cash flow 0.02 n/m 25.18
EV/EBITDA 5.73 n/m 0.66
EV/Sales n/m 1.44 9.02
Earnings yield 7,216.75% (27.13%) (32.88%)
Free cash flow yield 5,994.86% (52.80%) (23.13%)

Profitability

Metric LIANY VERU Biotechnology median
Gross margin 0.00% 43.39% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 70.96% (62.25%) (51.96%)
Return on assets 66.19% (42.29%) (46.06%)
Return on invested capital (450.47%) (464.03%) 0.00%

Growth

Metric LIANY VERU Biotechnology median
Revenue growth (TTM) — 14.18% 6.76%
EPS growth (last fiscal year) 75.44% 44.64% 29.88%
Revenue growth, 5-year CAGR — (11.89%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LIANY VERU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.03 4.42 4.97
Net debt to EBITDA 7.41 0.74 1.01

Dividend

Metric LIANY VERU Biotechnology median
Dividend yield 0.00% — 0.41%
Payout ratio — — —

Size

Metric LIANY VERU Biotechnology median
Market cap 34.19m 35.12m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack